

EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
The pharmaceutical industry is experiencing its most significant transformation in decades. AI is slashing drug development timelines from 10-15 years to 18-24 months and reducing costs from $2.6 billion to tens of millions—making previously impossible treatments financially feasible. Sam and Mac explore how AI is…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Inside AsembleAI: DeepTech, AI & Science
See all episodes →
EP 57: Ai4 Podcast - Why "The Context Layer" Is What Enterprise AI Is Actually Missing | Andrei Manolache, Designverse

EP 56: Ai4 Podcast - Why AI-Generated Code Needs Its Own Kind of Security | Anand Revashetti, Lineaje

Ep 55: Ai4 Podcast - Turning 35 Years of Paper Archives into AI Training Data | Dilo Wijesuriya, ARC
Similar episodes from other shows
More like Inside AsembleAI: DeepTech, AI & Science →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech

🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery

How AI is saving billions of years of human research time | Max Jaderberg

Daphne Koller on drug discovery and AI
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.